Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4724 ARTÍCULOS , VIENDO DEL 2116 AL 2130

Redox active metals in neurodegenerative diseases

Acevedo K, Masaldan S, Opazo CM, Bush AI.

J Biol Inorg Chem. 2019 Dec;24(8):1141-1157. doi: 10.1007/s00775-019-01731-9. Epub 2019 Oct 24.

A Systematic Review of Case-Identification Algorithms Based on Italian Healthcare Administrative Databases for Three Relevant Diseases of the Nervous System: Parkinson's Disease, Multiple Sclerosis, and Epilepsy

Canova C, Danieli S, Barbiellini Amidei C, Simonato L, Di Domenicantonio R, Cappai G, Bargagli AM.

Epidemiol Prev. 2019 Jul-Aug;43(4 Suppl 2):62-74. doi: 10.19191/EP19.4.S2.P062.093.

Parkinson disease: Enhance nursing knowledge

Vacca VM Jr.

Nursing. 2019 Nov;49(11):24-32. doi: 10.1097/01.NURSE.0000585896.59743.21.

[Remote assessment of idiopathic Parkinson's disease : Developments in diagnostics, monitoring and treatment]

Kleinholdermann U, Melsbach J, Pedrosa DJ.

Nervenarzt. 2019 Dec;90(12):1232-1238. doi: 10.1007/s00115-019-00818-7.

Levodopa treatment in Parkinson's disease: earlier or later?

Paolini Paoletti F, Tambasco N, Parnetti L.

Ann Transl Med. 2019 Sep;7(Suppl 6):S189. doi: 10.21037/atm.2019.07.36.

A quick test of cognitive speed can predict development of dementia in Parkinson's disease

Jalakas M, Palmqvist S, Hall S, Svärd D, Lindberg O, Pereira JB, van Westen D, Hansson O.

Sci Rep. 2019 Oct 28;9(1):15417. doi: 10.1038/s41598-019-51505-1.

The Genetic Architecture of Parkinson Disease in Spain: Characterizing Population-Specific Risk, Differential Haplotype Structures, and Providing Etiologic Insight

Bandres-Ciga S, Ahmed S, Sabir MS, Blauwendraat C, Adarmes-Gómez AD, Bernal-Bernal I, Bonilla-Toribio M, Buiza-Rueda D, Carrillo F, Carrión-Claro M, Gómez-Garre P, Jesús S, Labrador-Espinosa MA, Macias D, Méndez-Del-Barrio C, Periñán-Tocino T, Tejera-Parrado C, Vargas-González L, Diez-Fairen M, Alvarez I, Tartari JP, Buongiorno M, Aguilar M, Gorostidi A, Bergareche JA, Mondragon E, Vinagre-Aragon A, Croitoru I, Ruiz-Martínez J, Dols-Icardo O, Kulisevsky J, Marín-Lahoz J, Pagonabarraga J, Pascual-Sedano B, Ezquerra M, Cámara A, Compta Y, Fernández M, Fernández-Santiago R, Muñoz E, Tolosa E, Valldeoriola F, Gonzalez-Aramburu I, Sanchez Rodriguez A, Sierra M, Menéndez-González M, Blazquez M, Garcia C, Suarez-San Martin E, García-Ruiz P, Martínez-Castrillo JC, Vela-Desojo L, Ruz C, Barrero FJ, Escamilla-Sevilla F, Mínguez-Castellanos A, Cerdan D, Tabernero C, Gomez Heredia MJ, Perez Errazquin F, Romero-Acebal M, Feliz C, Lopez-Sendon JL, Mata M, Martínez Torres I, Kim JJ, Dalgard CL; American Genome Center; Brooks J, Saez-Atienzar S, Gibbs JR, Jorda R, Botia JA, Bonet-Ponce L, Morrison KE, Clarke C, Tan M, Morris H, Edsall C, Hernandez D, Simon-Sanchez J, Nalls MA, Scholz SW, Jimenez-Escrig A, Duarte J, Vives F, Duran R, Hoenicka J, Alvarez V, Infante J, Marti MJ, Clarimón J, López de Munain A, Pastor P, Mir P, Singleton A; International Parkinson Disease Genomics Consortium.

Mov Disord. 2019 Dec;34(12):1851-1863. doi: 10.1002/mds.27864. Epub 2019 Oct 29.

Dynamic interaction of genetic risk factors and cocaine abuse in the background of Parkinsonism - a case report

Illés A, Balicza P, Molnár V, Bencsik R, Szilvási I, Molnar MJ.

BMC Neurol. 2019 Oct 28;19(1):260. doi: 10.1186/s12883-019-1496-y.

Intranasal delivery of mucoadhesive nanocarriers: a viable option for Parkinson's disease treatment?

Rehman S, Nabi B, Zafar A, Baboota S, Ali J.

Expert Opin Drug Deliv. 2019 Dec;16(12):1355-1366. doi: 10.1080/17425247.2019.1684895. Epub 2019 Nov 8.

Management of asymptomatic ventricular preexcitation

Mohan S, Balaji S.

Indian Pacing Electrophysiol J. 2019 Nov-Dec;19(6):232-239. doi: 10.1016/j.ipej.2019.10.001. Epub 2019 Oct 25.

Opicapone for the treatment of Parkinson's disease: an update

Salamon A, Zádori D, Szpisjak L, Klivényi P, Vécsei L.

Expert Opin Pharmacother. 2019 Dec;20(18):2201-2207. doi: 10.1080/14656566.2019.1681971. Epub 2019 Oct 31.

Animal Models for Parkinson's Disease Research: Trends in the 2000s

Kin K, Yasuhara T, Kameda M, Date I.

Int J Mol Sci. 2019 Oct 30;20(21):5402. doi: 10.3390/ijms20215402.

Effects of augmenting cholinergic neurotransmission on balance in Parkinson's disease

Mancini M, Chung K, Zajack A, Martini DN, Ramsey K, Lapidus J, Horak FB, Nutt JG.

Parkinsonism Relat Disord. 2019 Dec;69:40-47. doi: 10.1016/j.parkreldis.2019.10.022. Epub 2019 Oct 23.

Vibrating socks to improve gait in Parkinson's disease

Koopman CM, Lutters E, Nonnekes J, Bloem BR, van Vugt JPP, Tjepkema-Cloostermans MC.

Parkinsonism Relat Disord. 2019 Dec;69:59-60. doi: 10.1016/j.parkreldis.2019.10.021. Epub 2019 Oct 23.

Glucagon-Like Peptide-1: A Focus on Neurodegenerative Diseases

Grieco M, Giorgi A, Gentile MC, d'Erme M, Morano S, Maras B, Filardi T.

Front Neurosci. 2019 Oct 18;13:1112. doi: 10.3389/fnins.2019.01112. eCollection 2019.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias